Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Kasopefoluwa Y Oguntuyo"'
Autor:
Alisa Fox, Jessica Marino, Fatima Amanat, Kasopefoluwa Y Oguntuyo, Jennifer Hahn-Holbrook, Benhur Lee, Susan Zolla-Pazner, Rebecca L Powell
Publikováno v:
PLoS ONE, Vol 17, Iss 3, p e0249723 (2022)
Approximately 10% of infants infected with SARS-CoV-2 will experience COVID-19 illness requiring advanced care. A potential mechanism to protect this population is passive immunization via the milk of a previously infected person. We and others have
Externí odkaz:
https://doaj.org/article/8df338ce46a54b31922fb74b78662383
Autor:
Diego S Ojeda, María Mora Gonzalez Lopez Ledesma, Horacio M Pallarés, Guadalupe S Costa Navarro, Lautaro Sanchez, Beatriz Perazzi, Sergio M Villordo, Diego E Alvarez, BioBanco Working Group, Marcela Echavarria, Kasopefoluwa Y Oguntuyo, Christian S Stevens, Benhur Lee, Jorge Carradori, Julio J Caramelo, Marcelo J Yanovsky, Andrea V Gamarnik
Publikováno v:
PLoS Pathogens, Vol 17, Iss 1, p e1009161 (2021)
We report the emergency development and application of a robust serologic test to evaluate acute and convalescent antibody responses to SARS-CoV-2 in Argentina. The assays, COVIDAR IgG and IgM, which were produced and provided for free to health auth
Externí odkaz:
https://doaj.org/article/f52da82c760941bfa762fd2795935185
Autor:
Arnold Park, Patrick Hong, Sohui T Won, Patricia A Thibault, Frederic Vigant, Kasopefoluwa Y Oguntuyo, Justin D Taft, Benhur Lee
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 3, Iss C (2016)
The advent of RNA-guided endonuclease (RGEN)-mediated gene editing, specifically via CRISPR/Cas9, has spurred intensive efforts to improve the efficiency of both RGEN delivery and targeted mutagenesis. The major viral vectors in use for delivery of C
Externí odkaz:
https://doaj.org/article/a47e9ef0babb4529a61546002c818f9a
Autor:
Alice J. Stelfox, Kasopefoluwa Y. Oguntuyo, Ilona Rissanen, Karl Harlos, Robert Rambo, Benhur Lee, Thomas A. Bowden
Publikováno v:
mBio, Vol 14, Iss 5 (2023)
ABSTRACT Increased viral surveillance has led to the isolation and identification of numerous uncharacterized paramyxoviruses, rapidly expanding our understanding of paramyxoviral diversity beyond the bounds of known genera. Despite this diversity, a
Externí odkaz:
https://doaj.org/article/92817af984f24736a7422fd40ac06895
Autor:
Jéromine Klingler, Gregory S. Lambert, Juan C. Bandres, Rozita Emami-Gorizi, Arthur Nádas, Kasopefoluwa Y. Oguntuyo, Fatima Amanat, Maria C. Bermúdez-González, Charles Gleason, Giulio Kleiner, Viviana Simon, Benhur Lee, Susan Zolla-Pazner, Chitra Upadhyay, Catarina E. Hioe
Publikováno v:
iScience, Vol 25, Iss 12, Pp 105608- (2022)
Summary: A fraction of patients with COVID-19 develops severe disease requiring hospitalization, while the majority, including high-risk individuals, experience mild symptoms. Severe disease has been associated with higher levels of antibodies and in
Externí odkaz:
https://doaj.org/article/b97299b033a14b1b9f3ad1f5125d6af4
Autor:
Satoshi Ikegame, Jillian C. Carmichael, Heather Wells, Robert L. Furler O’Brien, Joshua A. Acklin, Hsin-Ping Chiu, Kasopefoluwa Y. Oguntuyo, Robert M. Cox, Aum R. Patel, Shreyas Kowdle, Christian S. Stevens, Miles Eckley, Shijun Zhan, Jean K. Lim, Ethan C. Veit, Matthew J. Evans, Takao Hashiguchi, Edison Durigon, Tony Schountz, Jonathan H. Epstein, Richard K. Plemper, Peter Daszak, Simon J. Anthony, Benhur Lee
Publikováno v:
Nature Microbiology.
Publikováno v:
Current Opinion in Virology
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), like other coronaviruses, relies on a flexible array of entry mechanisms, driven by the spike (S) protein. Entry is dependent on proteolytic priming, activation, and receptor binding; all
Autor:
Victoria A. Avanzato, Trenton Bushmaker, Kasopefoluwa Y. Oguntuyo, Kwe Claude Yinda, Helen M. E. Duyvesteyn, Robert Stass, Kimberly Meade-White, Rebecca Rosenke, Tina Thomas, Greg Saturday, Katie J. Doores, Benhur Lee, Thomas A. Bowden, Vincent J. Munster
Nipah virus (NiV) is a highly pathogenic paramyxovirus capable of causing severe respiratory and neurologic disease in humans. Currently, there are no licensed vaccines or therapeutics against NiV, underscoring the urgent need for the development of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99bb64714e85743453da2e77bb4ec202
https://doi.org/10.1101/2022.09.26.507980
https://doi.org/10.1101/2022.09.26.507980
Autor:
Kuan-Ting Liu, Yu-Nong Gong, Chung-Guei Huang, Peng-Nien Huang, Kar-Yee Yu, Hou-Chen Lee, Sun-Che Lee, Huan-Jung Chiang, Yu-An Kung, Yueh-Te Lin, Mei-Jen Hsiao, Po-Wei Huang, Sheng-Yu Huang, Hsin-Tai Wu, Chih-Ching Wu, Rei-Lin Kuo, Kuan-Fu Chen, Chuan-Tien Hung, Kasopefoluwa Y. Oguntuyo, Christian S. Stevens, Shreyas Kowdle, Hsin-Ping Chiu, Benhur Lee, Guang-Wu Chen, Shin-Ru Shih
Publikováno v:
mSphere. 7(1)
Considering the urgent demand for faster methods to quantify neutralizing antibody titers in patients with coronavirus (CoV) disease 2019 (COVID-19), developing an analytical model or method to replace the conventional virus neutralization test (NT)
Autor:
Kasopefoluwa Y. Oguntuyo, Lauren L. Donnangelo, Guangjing Zhu, Stephen Ward, Abhik Bhattacharaya
Publikováno v:
ACG Case Reports Journal. 9:e00894